A dose of iodinated contrast over the maximum allowable contrast dose (MACD) of 300 mL has been considered as a major factor leading to acute kidney injury (AKI) [1]. However, we found that the incidence of contrast-associated acute kidney injury (CA-AKI) was low (3.5%, 23/651) in patients administered with >300 mL iodixanol [2].
